All news
Spotlight on Early-Onset Digestive Cancers: DiCE Hosts High-Level Policy Meeting at the European Parliament
26 May 2025Riding on the momentum of ENTERO2024, DiCE spotlighted early-onset digestive cancers at the European Parliament, uniting MEPs, experts, and patient...
Global Collaboration for Early-Onset Colorectal Cancer: Join the Conversation
24 May 2025We’re proud to join the Global Early Onset Colorectal Cancer Think Tank this June in Barcelona. Alongside Fight CRC, we’re gathering patient an...
DiCE Participates in AMMF’s 2025 European Cholangiocarcinoma Conference
24 May 2025From 7–9 May, DiCE virtually joined the AMMF European Cholangiocarcinoma Conference, hosted in London. Organised by AMMF, the UK-based charity de...
Shaping the Future: Meet the Nominees for DiCE’s New Board of Directors
28 April 2025Meet the nominees for DiCE’s next Board of Directors. Representing national organisations, each candidate brings experience in patient advocacy, ...
Global Oncology Partnership Panel Focuses on Patient Engagement
11 April 2025Patient advocates gathered at the first Global Oncology Partnership Panel (GOPP) meeting hosted by Boehringer Ingelheim in Germany. Workshops and d...
Ensuring Access to Critical Medicines: What Digestive Cancer Patients Need from the Critical Medicines Act
24 March 2025The European Commission’s proposal for a Critical Medicines Act marks a significant step toward securing the supply, availability, and accessib...
2025 Year of the Patient
16 February 2025At Digestive Cancers Europe (DiCE), we have always placed patients at the heart of our mission—amplifying their voices, advocating for their nee...
Can a Targeted Cancer Drug Help Prevent Recurrence in Gastro-Oesophageal Cancer?
15 February 2025DECIPHER Trial for patients with gastro-oesophageal adenocarcinoma, tests whether a targeted cancer drug can help patients with a hard-to-treat can...
Educational Programme on Metastatic Pancreatic Cancer Now Available
15 February 2025Metastatic pancreatic ductal adenocarcinoma (mPDAC) is an aggressive and often late-diagnosed cancer with poor prognoses. Early detection remains c...
ESMO Expands Globally with New Patient Advocates Working Group
14 February 2025ESMO is proud to announce the launch of its newly globalised Patient Advocates Working Group (PAWG), now led by Zorana Maravic as Chair. This miles...